or Try an Advanced Search...

    Technical Analysis for TSBX - Turnstone Biologics Corp.

    Grade Last Price % Change Price Change
    F 2.76 -4.83% -0.14
    TSBX closed down 4.83 percent on Friday, April 26, 2024, on 69 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical TSBX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Fell Below 20 DMA Bearish -4.83%
    Bollinger Band Squeeze Range Contraction -4.83%
    Wide Bands Range Expansion -4.83%
    20 DMA Support Bullish -10.10%
    Bollinger Band Squeeze Range Contraction -10.10%
    Doji - Bearish? Reversal -10.10%
    BB Squeeze Started Range Contraction -10.10%
    Older End-of-Day Signals for TSBX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 16 hours ago
    Down 5% about 19 hours ago
    20 DMA Resistance about 20 hours ago
    Up 3% about 21 hours ago
    Up 2% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TSBX Chart by TradingView
    Basic chart:

    Profile

    Turnstone Biologics Corp. Description

    Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL therapy is based upon the identification, selection, and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TILs that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in two Phase 1 studies in patients with melanoma, breast cancer, and colorectal cancer, and the Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Solid Tumors Immunotherapy Breast Cancer Melanoma Colorectal Cancer Tumor Infiltrating Lymphocytes

    Is TSBX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 16 Turnstone Biologics Appoints William Waddill to its Board of Directors
    Mar 22 Turnstone Biologics GAAP EPS of -$0.73 beats by $0.25
    Mar 21 Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
    Mar 2 Turnstone Biologics Corp. (NASDAQ:TSBX) institutional investors have had a good week as stock gains 34%
    Feb 21 Turnstone Biologics to Participate in Upcoming Investor Conferences
    Feb 20 Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
    Jan 21 Here's Why Turnstone Biologics (NASDAQ:TSBX) Must Use Its Cash Wisely
    Nov 27 Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
    Nov 10 Turnstone Biologics GAAP EPS of -$1.00
    Nov 10 Turnstone Biologics GAAP EPS of $1.00
    See more TSBX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.2
    52 Week Low 1.625
    Average Volume 188,551
    200-Day Moving Average 0.00
    50-Day Moving Average 3.22
    20-Day Moving Average 3.02
    10-Day Moving Average 2.83
    Average True Range 0.38
    RSI (14) 44.75
    ADX 24.72
    +DI 19.41
    -DI 14.50
    Chandelier Exit (Long, 3 ATRs) 2.74
    Chandelier Exit (Short, 3 ATRs) 3.69
    Upper Bollinger Bands 3.58
    Lower Bollinger Band 2.46
    Percent B (%b) 0.27
    BandWidth 36.89
    MACD Line -0.07
    MACD Signal Line -0.06
    MACD Histogram -0.012
    Fundamentals Value
    Market Cap 63.74 Million
    Num Shares 23.1 Million
    EPS -2.27
    Price-to-Earnings (P/E) Ratio -1.22
    Price-to-Sales 2.13
    Price-to-Book 0.56
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.21
    Resistance 3 (R3) 3.25 3.15 3.14
    Resistance 2 (R2) 3.15 3.03 3.13 3.11
    Resistance 1 (R1) 2.95 2.96 2.90 2.91 3.08
    Pivot Point 2.85 2.85 2.82 2.83 2.85
    Support 1 (S1) 2.65 2.73 2.60 2.61 2.44
    Support 2 (S2) 2.55 2.66 2.53 2.41
    Support 3 (S3) 2.35 2.55 2.39
    Support 4 (S4) 2.31